Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

PSB-1114 (triethylamine)

PSB-1114 triethylamine is a potent, enzymatically stable, and subtype-selective P2Y2 receptor agonist with an EC50 of 134 nM. PSB-1114 triethylamine displays >50-fold selectivity versus the P2Y4 (EC50 of 9.3 μM) and P2Y6 (EC50 of 7.0 μM) receptors[1].

Product Specifications

UNSPSC

12352128

Target

P2Y Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/psb-1114-triethylamine.html

Purity

95.0

Solubility

H2O : ≥ 100 mg/mL

Smiles

CCN(CC)CC.O[C@H]1[C@H](N2C(NC(C=C2)=S)=O)O[C@H](COP(OP(C(F)(F)P(O)(O)=O)(O)=O)(O)=O)[C@H]1O.[x]

Molecular Formula

C10H15F2N2O13P3S.xC6H15N

References & Citations

[1]El-Tayeb A, et al. Structural modifications of UMP, UDP, and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6 receptors. J Med Chem. 2011 Apr 28;54 (8) :2878-90.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Human SERPINI2 (NM_006217) AAV Particle
RC206445A1V 250 µL

Human SERPINI2 (NM_006217) AAV Particle

Ask
View Details
Lentiviral mouse Ercc4 shRNA (UAS) - Lentiviral mouse Ercc4 shRNA (UAS) (100)
GTR15197298 1 Vial

Lentiviral mouse Ercc4 shRNA (UAS) - Lentiviral mouse Ercc4 shRNA (UAS) (100)

Ask
View Details
MRPL37 siRNA (Mouse)
MBS8234462-01 15 nmol

MRPL37 siRNA (Mouse)

Ask
View Details
MRPL37 siRNA (Mouse)
MBS8234462-02 30 nmol

MRPL37 siRNA (Mouse)

Ask
View Details
MRPL37 siRNA (Mouse)
MBS8234462-03 5x 30 nmol

MRPL37 siRNA (Mouse)

Ask
View Details
Ligelizumab Biosimilar - Research Grade
ICH5644-10mg 10 mg (2x 5 mg)

Ligelizumab Biosimilar - Research Grade

Ask
View Details